Caffeine may play a role in processes related to aging by activating a system in cells that helps manage energy and stress, according to a study from Queen Mary University of London. Published in the journal Microbial Cell, the research suggests that caffeine influences a biological pathway involved in growth, stress resistance, and DNA repair—processes that are closely linked to how organisms age. The study used fission yeast, a single-celled organism that shares many biological traits with human cells, to explore these effects. The researchers found that caffeine activates a cellular system known as AMPK (AMP-activated protein kinase), which helps regulate energy balance and allows cells to respond to low energy levels. This is different from the TOR (Target of Rapamycin) pathway, which had previously been linked to caffeine’s effects on cell longevity. Dr. Charalampos (Babis) Rallis, senior author of the study, said caffeine helps “flip that switch,” activating AMPK and potentially influencing cellular functions related to aging. AMPK is also connected to metformin, a common diabetes drug that has sparked interest in longevity research. The study emphasizes that the interaction between caffeine and AMPK is significant, as this pathway exists in both yeast and humans. Although the experiments were conducted on fission yeast, the presence of AMPK in humans suggests that the findings could guide future research into aging and related diseases. The study indicates that caffeine might support healthier aging by influencing processes like DNA repair, stress responses, and growth regulation. However, it does not prove that drinking coffee will extend human lifespan. The research opens the door for further studies on how caffeine or similar compounds might influence aging through diet, lifestyle choices, or new medical treatments.